Bioavailability of Once- and Twice-Daily Regimens of Didanosine in Human Immunodeficiency Virus-Infected Children

The bioavailability of didanosine at 180 mg/m(2) once daily was compared to that at 90 mg/m(2) twice daily in 24 children with advanced human immunodeficiency virus infection. Children were studied at steady state using optimal sampling and prior pharmacokinetic parameter estimates. Relative bioavai...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Abreu, Thalita, Plaisance, Karen, Rexroad, Vivian, Nogueira, Susie, Oliveira, Ricardo Hugo, Evangelista, Lucia A., Rangel, Rosana, Silva, Irene S., Knupp, Cathy, Lambert, John S.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89876/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770783/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1375-1376.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!